{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:34:34Z","timestamp":1790613274993,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>A hybrid approach with very high-power short-duration (vHPSD) posteriorly and ablation-index guided HPSD (50 W) anteriorly seems to be an optimal balance between efficiency and effectiveness for point-by-point pulmonary vein isolation (PVI). The aim of the current study is to compare vHPSD\/HPSD ablation to cryoballoon ablation (CBA) in patients with symptomatic atrial fibrillation (AF).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and results<\/jats:title>\n            <jats:p>In this retrospective single-center study, we identified 110 consecutive patients who underwent their first PVI with either vHPSD\/HPSD (<jats:italic>n<\/jats:italic>\u2009=\u200954) or CBA (<jats:italic>n<\/jats:italic>\u2009=\u200956). We compared procedural efficacy, efficiency, safety, and long-term outcomes. Baseline characteristics of both groups were comparable; however, patients in the vHPSD\/HPSD group had larger left atrial volume index (35, IQR 27\u201345 vs. 28, IQR 21\u201336\u00a0ml\/m<jats:sup>2<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009=\u20090.005). Complete PVI was achieved in all patients except two CBA cases (100% vs. 96.4%, <jats:italic>P<\/jats:italic>\u2009=\u20090.50). First-pass isolation rate was 79.6% in the hybrid group. Procedure times were similar between groups (53, IQR 47\u201363 vs. 55, IQR 49\u201365\u00a0min, <jats:italic>P<\/jats:italic>\u2009=\u20090.35), but fluoroscopy time was shorter in the vHPSD\/HPSD group (3.9 [2.7, 5.6] vs. 11.9 [9.3, 14.9] min, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). There were 3 temporary phrenic nerve palsies (5.4%) in the CBA group which resolved within 1\u00a0year. The 1-year freedom from any atrial tachyarrhythmias after a single procedure was similar between groups (68.5% vs. 73.2%, <jats:italic>P<\/jats:italic>\u2009=\u20090.56). During repeat procedure, the durability of PVI was comparable.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The use of vHPSD\/HPSD ablation renders point-by-point PVI as fast and effective as CBA. Furthermore, it has lower radiation exposure compared to CBA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s10840-025-01982-4","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T06:15:03Z","timestamp":1736576103000},"page":"1179-1188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimized workflow with hybrid (very) high-power short-duration radiofrequency ablation renders point-by-point pulmonary vein isolation as fast and effective as cryoballoon ablation"],"prefix":"10.1007","volume":"68","author":[{"given":"Marco","family":"Fusaroli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit E.","family":"Bhagwandien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sip A.","family":"Wijchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakthawar K.","family":"Mahmoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4520-2725","authenticated-orcid":false,"given":"Sing-Chien","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"1982_CR1","doi-asserted-by":"crossref","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, Lochen ML, Lumbers RT, Maesen B, Molgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D and Group ESCSD. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45:3314-3414","DOI":"10.1093\/eurheartj\/ehae176"},{"key":"1982_CR2","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy VY, Gerstenfeld EP, Natale A, Whang W, Cuoco FA, Patel C, Mountantonakis SE, Gibson DN, Harding JD, Ellis CR, Ellenbogen KA, DeLurgio DB, Osorio J, Achyutha AB, Schneider CW, Mugglin AS, Albrecht EM, Stein KM, Lehmann JW, Mansour M, Investigators A. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023;389:1660\u201371.","journal-title":"N Engl J Med"},{"key":"1982_CR3","doi-asserted-by":"crossref","unstructured":"Kuck KH, Furnkranz A, Chun KR, Metzner A, Ouyang F, Schluter M, Elvan A, Lim HW, Kueffer FJ, Arentz T, Albenque JP, Tondo C, Kuhne M, Sticherling C, Brugada J, Fire and Investigators ICE. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858\u20132865.","DOI":"10.1093\/eurheartj\/ehw285"},{"key":"1982_CR4","doi-asserted-by":"crossref","unstructured":"Kuck KH, Brugada J, Furnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, Fire and Investigators ICE. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235\u201345.","DOI":"10.1056\/NEJMoa1602014"},{"key":"1982_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jacep.2022.12.020","volume":"9","author":"AC Lee","year":"2023","unstructured":"Lee AC, Voskoboinik A, Cheung CC, Yogi S, Tseng ZH, Moss JD, Dewland TA, Lee BK, Lee RJ, Hsia HH, Marcus GM, Vedantham V, Chieng D, Kistler PM, Dillon W, Vittinghoff E, Gerstenfeld EP. A randomized trial of high vs standard power radiofrequency ablation for pulmonary vein isolation: SHORT-AF. JACC Clin Electrophysiol. 2023;9:1038\u201347.","journal-title":"JACC Clin Electrophysiol"},{"key":"1982_CR6","doi-asserted-by":"crossref","unstructured":"Ravi V, Poudyal A, Abid QU, Larsen T, Krishnan K, Sharma PS, Trohman RG and Huang HD. High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2021;23:710\u2013721.","DOI":"10.1093\/europace\/euaa327"},{"key":"1982_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/europace\/euz342","volume":"22","author":"M Kottmaier","year":"2020","unstructured":"Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V, Telishevska M, Otgonbayar U, Koch-Buttner K, Lennerz C, Bartkowiak M, Kornmayer M, Rousseva E, Brkic A, Grebmer C, Kolb C, Hessling G, Deisenhofer I. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Europace. 2020;22:388\u201393.","journal-title":"Europace"},{"key":"1982_CR8","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1111\/jce.14219","volume":"30","author":"S Chen","year":"2019","unstructured":"Chen S, Schmidt B, Bordignon S, Urbanek L, Tohoku S, Bologna F, Angelkov L, Garvanski I, Tsianakas N, Konstantinou A, Trolese L, Weise F, Perrotta L, Chun KRJ. Ablation index-guided 50 W ablation for pulmonary vein isolation in patients with atrial fibrillation: Procedural data, lesion analysis, and initial results from the FAFA AI High Power Study. J Cardiovasc Electrophysiol. 2019;30:2724\u201331.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1982_CR9","doi-asserted-by":"crossref","unstructured":"Wielandts JY, Kyriakopoulou M, Almorad A, Hilfiker G, Strisciuglio T, Phlips T, El Haddad M, Lycke M, Unger P, Le Polain de Waroux JB, Vandekerckhove Y, Tavernier R, Duytschaever M and Knecht S. Prospective randomized evaluation of high power during CLOSE-guided pulmonary vein isolation: the POWER-AF study. Circ Arrhythm Electrophysiol. 2021;14:e009112.","DOI":"10.1161\/CIRCEP.120.009112"},{"key":"1982_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jacep.2019.04.009","volume":"5","author":"VY Reddy","year":"2019","unstructured":"Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A, Duytschaever MF, Martinek M, Natale A, Knecht S, Neuzil P, Purerfellner H. Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial. JACC Clin Electrophysiol. 2019;5:778\u201386.","journal-title":"JACC Clin Electrophysiol"},{"key":"1982_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/europace\/euac243","volume":"25","author":"CH Heeger","year":"2023","unstructured":"Heeger CH, Sano M, Popescu SS, Subin B, Feher M, Phan HL, Kirstein B, Vogler J, Eitel C, Hatahet S, Kuck KH, Tilz RR. Very high-power short-duration ablation for pulmonary vein isolation utilizing a very-close protocol-the FAST AND FURIOUS PVI study. Europace. 2023;25:880\u20138.","journal-title":"Europace"},{"key":"1982_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.hrthm.2020.10.021","volume":"18","author":"M Takigawa","year":"2021","unstructured":"Takigawa M, Kitamura T, Martin CA, Fuimaono K, Datta K, Joshi H, Constantin M, Bourier F, Cheniti G, Duchateau J, Pambrun T, Denis A, Derval N, Sacher F, Cochet H, Hocini M, Haissaguerre M, Jais P. Temperature- and flow-controlled ablation\/very-high-power short-duration ablation vs conventional power-controlled ablation: comparison of focal and linear lesion characteristics. Heart Rhythm. 2021;18:553\u201361.","journal-title":"Heart Rhythm"},{"key":"1982_CR13","doi-asserted-by":"crossref","unstructured":"O'Neill L, El Haddad M, Berte B, Kobza R, Hilfiker G, Scherr D, Manninger M, Wijnmaalen AP, Trines SA, Wielandts JY, Gillis K, Lycke M, De Becker B, Tavernier R, Le Polain De Waroux JB, Knecht S and Duytschaever M. Very high-power ablation for contiguous pulmonary vein isolation: results from the randomized POWER PLUS trial. JACC Clin Electrophysiol. 2023;9:511\u2013522.","DOI":"10.1016\/j.jacep.2022.10.039"},{"key":"1982_CR14","doi-asserted-by":"crossref","unstructured":"Kariki O, Mililis P, Saplaouras A, Efremidis T, Tsetika EG, Martinos A, Girginoudi E, Dragasis S, Letsas KP and Efremidis M. Comparison of very-high power short duration radiofrequency ablation strategies for pulmonary vein isolation in paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2024.","DOI":"10.1007\/s10840-024-01856-1"},{"key":"1982_CR15","doi-asserted-by":"crossref","unstructured":"Chen S. Very high-power short duration 90 W\/4 s (vHPSD) vs. vHPSD-combined ablation index-guided 50W ablation (hybrid) approach for pulmonary vein isolation in treating atrial fibrillation: have we found the best radiofrequency recipe? J Interv Card Electrophysiol. 2024.","DOI":"10.1007\/s10840-024-01880-1"},{"key":"1982_CR16","first-page":"26","volume":"2024","author":"S Tzeis","year":"2024","unstructured":"Tzeis S, Trines SA, et al. European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2024;2024:26.","journal-title":"Europace"},{"key":"1982_CR17","doi-asserted-by":"publisher","first-page":"e012402","DOI":"10.1161\/CIRCEP.123.012402","volume":"17","author":"N Szegedi","year":"2024","unstructured":"Szegedi N, Sallo Z, Nagy VK, Osztheimer I, Hizoh I, Lakatos B, Boussoussou M, Orban G, Boga M, Ferencz AB, Komlosi F, Toth P, Perge P, Kovacs A, Merkely B, Geller L. Long-term durability of high- and very high-power short-duration PVI by invasive remapping: the HPSD remap study. Circ Arrhythm Electrophysiol. 2024;17:e012402.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1982_CR18","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/jce.13724","volume":"29","author":"F Bourier","year":"2018","unstructured":"Bourier F, Duchateau J, Vlachos K, Lam A, Martin CA, Takigawa M, Kitamura T, Frontera A, Cheniti G, Pambrun T, Klotz N, Denis A, Derval N, Cochet H, Sacher F, Hocini M, Haissaguerre M, Jais P. High-power short-duration versus standard radiofrequency ablation: insights on lesion metrics. J Cardiovasc Electrophysiol. 2018;29:1570\u20135.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1982_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/pace.15004","volume":"47","author":"L Lin","year":"2024","unstructured":"Lin L, Huang Y, Huang Q, Yu F, Mao Y. Meta-analysis of high-power short-duration versus cryoballoon ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2024;47:1013\u201324.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1982_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10840-022-01351-5","volume":"66","author":"G Chu","year":"2023","unstructured":"Chu G, Calvert P, Sidhu B, Mavilakandy A, Kotb A, Tovmassian L, Kozhuharov N, Bierme C, Denham N, Pius C, O\u2019Brien J, Ding WY, Luther V, Snowdon RL, Ng GA, Gupta D. Patient experience of very high power short duration radiofrequency ablation for atrial fibrillation under mild conscious sedation. J Interv Card Electrophysiol. 2023;66:445\u201353.","journal-title":"J Interv Card Electrophysiol"},{"key":"1982_CR21","doi-asserted-by":"publisher","first-page":"1124372","DOI":"10.1155\/2022\/1124372","volume":"2022","author":"N Pang","year":"2022","unstructured":"Pang N, Gao J, Zhang N, Zhang B, Wang R. Comparison of the different anesthesia strategies for atrial fibrillation catheter ablation: a systematic review and meta-analysis. Cardiol Res Pract. 2022;2022:1124372.","journal-title":"Cardiol Res Pract"},{"key":"1982_CR22","doi-asserted-by":"crossref","unstructured":"Riis-Vestergaard LD, Tonnesen J, Ruwald MH, Zorner CR, Middelfart C, Hein R, Johannessen A, Hansen J, Worck RH, Gislason G and Hansen ML. General anaesthesia compared to conscious sedation for first-time atrial fibrillation catheter ablation-a Danish nationwide cohort study. Europace. 2024;26.","DOI":"10.1093\/europace\/euae203"},{"key":"1982_CR23","doi-asserted-by":"crossref","unstructured":"Falasconi G, Penela D, Soto-Iglesias D, Francia P, Saglietto A, Turturiello D, Viveros D, Bellido A, Alderete J, Zaraket F, Franco-Ocana P, Huguet M, Camara O, Vatasescu R, Ortiz-Perez JT, Marti-Almor J and Berruezo A. Personalized pulmonary vein isolation with very high-power short-duration lesions guided by left atrial wall thickness: the QDOT-by-LAWT randomized trial. Europace. 2024;26.","DOI":"10.1093\/europace\/euae087"},{"key":"1982_CR24","doi-asserted-by":"publisher","first-page":"f419","DOI":"10.1093\/europace\/eux376","volume":"20","author":"T Phlips","year":"2018","unstructured":"Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y, Tavernier R, Duytschaever M. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the \u2019CLOSE\u2019-protocol. Europace. 2018;20:f419\u201327.","journal-title":"Europace"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-01982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-025-01982-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-01982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:09:01Z","timestamp":1757128141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-025-01982-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1982"],"URL":"https:\/\/doi.org\/10.1007\/s10840-025-01982-4","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Yap has received honoraria from Boston Scientific, Medtronic, Biotronik, Acutus Medical, and Sanofi. In addition, he has received research grants from Medtronic, Biotronik, and Boston Scientific. The other authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}